Chemoprophylaxis and intermittent treatment for preventing malaria in children

作者: Martin M Meremikwu , Sarah Donegan , Ekpereonne Esu , None

DOI: 10.1002/14651858.CD003756.PUB3

关键词:

摘要: Background Malaria causes repeated illness in children living endemic areas. Policies of giving antimalarial drugs at regular intervals (prophylaxis or intermittent treatment) are being considered for preschool children. Objectives To evaluate prophylaxis and treatment with to prevent malaria young malaria-endemic Search strategy We searched the Cochrane Infectious Diseases Group Specialized Register (August 2007), CENTRAL (The Library 2007, Issue 3), MEDLINE (1966 August EMBASE (1974 LILACS (1982 mRCT (February reference lists identified trials. also contacted researchers. Selection criteria Individually randomized cluster-randomized controlled trials comparing given placebo no drug aged one month six years less a area. Data collection analysis Two authors independently extracted data assessed methodological quality. used relative risk (RR) weighted mean difference 95% confidence (CI) meta-analyses. Where we detected heterogeneity it appropriate combine trials, random-effects model (REM). Main results Twenty-one (19,394 participants), including met inclusion criteria. Prophylaxis resulted fewer clinical episodes (RR 0.53, CI 0.38 0.74, REM; 7037 participants, 10 trials), severe anaemia 0.70, 0.52 0.94, 5445 9 hospital admissions any cause 0.64, 0.49 0.82; 3722 5 trials). did not detect number deaths from 0.90, 0.65 1.23; 7369 but do exclude potentially important difference. One trial reported three serious adverse events statistically significant between study groups (1070 participants). Eight measured morbidity mortality months two after stopping drugs; overall, there was difference, participant numbers were small. Authors' conclusions reduce

参考文章(113)
Asuzu Mc, Ogunba Eo, Oyediran Ab, Osunkoya Bo, Topley E, Bamgboye A, Williams Ai, Severe morbidity among children in a trial malaria chemoprophylaxis with pyrimethamine or chloroquine in Ibarapa, Nigeria. African journal of medicine and medical sciences. ,vol. 22, pp. 55- 63 ,(1993)
Karunakaran Cs, A clinical trial of malaria prophylaxis using a single dose of chloroquine at different intervals in an endemic malarious area. The Journal of tropical medicine and hygiene. ,vol. 83, pp. 195- 201 ,(1980)
Bruce-Chwatt Lj, Archibald Hm, Suppression of malaria with pyrimethamine in Nigerian schoolchildren. Bulletin of The World Health Organization. ,vol. 15, pp. 775- 784 ,(1956)
Deichmann U, Marsh K, Craig M, Snow Rw, Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bulletin of The World Health Organization. ,vol. 77, pp. 624- 640 ,(1999)
P Garner, AM G��lmezoglu, Drugs for preventing malaria-related illness in pregnant women and death in the newborn Cochrane Database of Systematic Reviews. ,(2002) , 10.1002/14651858.CD000169
J. Pividal, E. Streat, A. Schapira, V. Viktinski, Efficacy of dapsone with pyrimethamine (Maloprim) for malaria prophylaxis in Maputo, Mozambique. East African Medical Journal. ,vol. 69, pp. 303- 305 ,(1992)
A. B. G. Laing, Malaria suppression with fortnightly doses of pyrimethamine with sulfadoxine in the Gambia. Bulletin of The World Health Organization. ,vol. 43, pp. 513- 520 ,(1970)
S. Avery-Jones, G. Pringle, Observations on the early course of untreated falciparum malaria in semi-immune African children following a short period of protection. Bulletin of The World Health Organization. ,vol. 34, pp. 269- 272 ,(1966)